Methods: Patients aged 18 and older, with scientific T1four, N1-2, M0 breast most cancers who acquired neoadjuvant chemotherapy followed by axillary lymph node dissection between 2004 and 2016 on the Misericordia Hospital, in Edmonton Alberta had been identified from a prospectively maintained datab...